23Andme Financial Statements From 2010 to 2026
| MEDelisted Stock | USD 0.61 0.14 18.67% |
Check 23Andme Holding financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among 23Andme Holding's main balance sheet or income statement drivers, such as , as well as many indicators such as . 23Andme financial statements analysis is a perfect complement when working with 23Andme Holding Valuation or Volatility modules.
23Andme |
23Andme Holding Co Company Return On Asset Analysis
23Andme Holding's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current 23Andme Holding Return On Asset | -0.33 |
Most of 23Andme Holding's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, 23Andme Holding Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
CompetitionBased on the latest financial disclosure, 23Andme Holding Co has a Return On Asset of -0.3318. This is 96.21% lower than that of the Biotechnology sector and 95.59% lower than that of the Health Care industry. The return on asset for all United States stocks is 137.0% higher than that of the company.
23Andme Holding Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining 23Andme Holding's current stock value. Our valuation model uses many indicators to compare 23Andme Holding value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across 23Andme Holding competition to find correlations between indicators driving 23Andme Holding's intrinsic value. More Info.23Andme Holding Co is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value 23Andme Holding by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.About 23Andme Holding Financial Statements
23Andme Holding stakeholders use historical fundamental indicators, such as 23Andme Holding's revenue or net income, to determine how well the company is positioned to perform in the future. Although 23Andme Holding investors may analyze each financial statement separately, they are all interrelated. For example, changes in 23Andme Holding's assets and liabilities are reflected in the revenues and expenses on 23Andme Holding's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in 23Andme Holding Co. Please read more on our technical analysis and fundamental analysis pages.
23andMe Holding Co. operates as a consumer genetics testing company. The company was founded in 2006 and is headquartered in South San Francisco, California. 23Andme Holding is traded on NASDAQ Exchange in the United States.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in median. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Consideration for investing in 23Andme Stock
If you are still planning to invest in 23Andme Holding check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the 23Andme Holding's history and understand the potential risks before investing.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |